The role of kappa free light chains in the diagnosis of multiple sclerosis

5 Dec 2023
The role of kappa free light chains in the diagnosis of multiple sclerosis

Dr. Irene Treviño Frenk, head of clinical research, Centro Médico ABC, explores the current landscape of multiple sclerosis diagnosis, the risks of a false or delayed detection, and how using kappa free light chains as a surrogate marker could help us to better manage and understand how the disease is evolving.

About the company

Siemens Healthineers logo

Siemens Healthineers

Siemens Healthcare is dedicated to helping you get the most out of your investment throughout the entire product life cycle and beyond. We understand that investments in healthcare technology today will have profound effects on both your patients and your business for years to come. Our goal is to enable you to take technology further, profitability higher, and patient care to the next level.

4.4/5.0
|114 Reviews

Other videos from Siemens Healthineers

Links

Tags

Clinical ChemistryBiochemistry (or clinical chemistry) involves the analysis of bodily fluids using chemical tests. Techniques used include HPLC, chromatography, spectroscopy, mass spectrometry, immunochemical, electrophoresis, turbidometric / spectrophotometric assay, MRI and ISE analysis. Tests are often carried out on plasma or serum but urine (urinalysis) and fecal specimens are also processed.Multiple Sclerosis
The role of kappa free light chains in the diagnosis of multiple sclerosis